Abstract-The role of Cu/Zn-superoxide dismutase (SOD) in myocardial ischemic reperfusion injury was studied by using a mouse model with targeted disruption of the mouse Sod I gene. Inactivation of the functional mouse Sod I gene in hearts by gene targeting (Sod I ϩ/Ϫ ) resulted in a 50% reduction of Cu/Zn-SOD mRNA and significant reduction of Cu/Zn-SOD enzyme activity compared with that of wild-type Sod I ϩ/ϩ mice. Cu/Zn-SOD mRNA could not be detected in Sod I Ϫ/Ϫ heart. The isolated buffer-perfused hearts from the knockout mice devoid of any functional copy of the Sod I (Sod I Ϫ/Ϫ ) and matched nontransgenic control mice were subjected to 30 minutes of global ischemia followed by 2 hours of reperfusion. For both groups of mice, the postischemic functional recovery for the hearts was lower than the baseline, but the recovery for the Sod I Ϫ/Ϫ was less compared with the wild-type mice. Thus, the postischemic recovery of the developed force and the maximum first derivative of the developed force were consistently lower for the Sod I Ϫ/Ϫ mouse hearts compared with wild-type control hearts. The coronary flow was lower compared with the baseline levels for both groups of hearts, but there was no significant difference between the groups. The myocardial infarction determined from the ratio of infarct size/area of risk was higher for the Sod I Ϫ/Ϫ mice compared with the control mice. The amount of creatine kinase release from the wild-type mouse hearts was less compared with the Sod I Ϫ/Ϫ mouse hearts. In concert, a reduced amount of oxidative stress was found in the hearts of wild-type mice compared with Sod I Ϫ/Ϫ mouse hearts. These results documented that Sod I Ϫ/Ϫ mouse hearts were more susceptible to ischemic reperfusion injury compared with corresponding wild-type mouse hearts, suggesting that the Sod I gene constitutes an important defense element for the hearts. 
R eactive oxygen species, including superoxide and hydroxyl radicals, as well as oxidants such as hydrogen peroxide, have been implicated in the pathogenesis of myocardial ischemic reperfusion injury. [1] [2] [3] In biological tissue, superoxide anions are readily dismutated by superoxide dismutase (SOD) into hydrogen peroxide, which can then be converted into hydroxyl radical by a Fenton-type reaction. 4 SOD consists of a transition metal at the active center, and, depending on the transition metal, 3 types of SOD are known to exist, as follows: manganese SOD (Mn-SOD), copper/ zinc-SOD (Cu/Zn-SOD), and iron-SOD (Fe-SOD). The bestcharacterized SOD is Mn-SOD, which is primarily located in the soluble matrix of the mitochondria. In contrast, the Cu/Zn-SOD is exclusively located in the cytosol. Whereas the cardioprotective role of Mn-SOD is well established, 5, 6 very little is known about the role of Cu/Zn-SOD in myocardial protection.
Several recent studies have documented that Cu/Zn-SOD plays a crucial role in cellular protection associated with ischemia and reperfusion. For example, overexpression of Cu/Zn-SOD reduces hippocampal injury after global ischemia in transgenic mice. 7 Transgenic mice with increased Cu/Zn-SOD activity were found to be resistant to hepatic leukostasis and capillary no-reflow after gut ischemia/reperfusion. 8 Another recent study demonstrated prevention of postischemic injury by overexpressing Cu/Zn-SOD. 9 Adverse effects of Cu/Zn have also been reported. Overexpression of the human Cu/Zn-SOD in mice containing an amyotrophic lateral sclerosis mutation developed a disorder in the transgenic mice that closely resembled human amyotrophic lateral sclerosis. 10 Another study implicated Cu/Zn-SOD to be neurotoxic. 11 This study sought to examine the cardioprotective effects of Cu/Zn-SOD by using mice with targeted disruption of the mouse Sod I gene. The isolated perfused hearts from the knockout mice devoid of any functional copy of the Sod I gene (Sod I Ϫ/Ϫ ), as well as Sod I ϩ/Ϫ and matched wild-type mice, were subjected to an ischemia/reperfusion protocol. The results demonstrated impaired postischemic ventricular recovery and increased infarct size for the Sod I Ϫ/Ϫ mouse hearts compared with those from Sod I ϩ/Ϫ and wild-type controls, suggesting that Sod I Ϫ/Ϫ mouse hearts are more susceptible to ischemic reperfusion injury.
Materials and Methods

Targeted Disruption of Mouse SOD1 Gene
Mouse Sod1 genomic clones were isolated from a 129/SVJ genomic library (Stratagene) by screening with a rat SOD I cDNA probe. 12 An Ϸ7.2-kb SacI genomic fragment, which contains the entire mouse SOD I gene, was isolated from clone 30 and used in construction of the gene targeting vector. To inactivate the mouse SOD I gene, the SmaI and HindIII restriction sites flanking the SmaI-HindIII fragment, which contains sequences from introns 1 to 4, were converted into XhoI sites by linker ligation and then inserted into the XhoI site in plasmid vector pPNT 13 (generously provided by Dr Richard Mulligan, Massachusetts Institute of Technology) (Figure 1 ). Similarly, linker ligation was also used to clone the EcoRI-SalI fragment containing the 3Ј-flanking sequence of the gene into the BamHI site in the pPNT vector.
The Sod1 targeting vector, in which exon 5 was deleted, was linearized by HindIII digestion and transfected into R1 ES cells 14 (a generous gift from Dr Andras Nagy, Mount Sinai Hospital at Toronto, Ontario, Canada). Clones resistant to G418 and ganciclovir (a gift from Syntex Inc, Palo Alto, CA) were screened by Southern blot analysis using a probe 5Ј external to the genomic sequence present in the targeting vector ( Figure 1 ). Targeted clones were microinjected into C57BL/6 blastocysts following the standard procedure. 15 Chimeric mice with near 100% chimerism were generated using Sod1 knockout clone 5 and showed 100% transmission of the 129/SVJ chromosomes. Mice (Sod I Ϫ/Ϫ , Sod I ϩ/Ϫ , and wild-type) were anesthetized, and the hearts were excised after thoracotomy. The aorta was cannulated, and the heart was perfused with Krebs-Henseleit bicarbonate buffer by the retrograde Langendorff method. 16 A 4-0 silk suture on a round-bodied needle was passed through the apex of the heart and attached to the apex, which in turn was attached to a force transducer. The heart rate, heart-developed force (dF), and first derivative of dF (dF/dt) were recorded. 16 The hearts of all mice were subjected to 30 minutes of ischemia followed by 2 hours of reperfusion.
Isolated Mouse Heart Preparation and Measurement of Contractile Function
Assessment of Cellular Injury
Creatine kinase (CK) release from the heart was estimated in the perfusate to assess cellular injury. At the end of reperfusion, a 10% (wt/vol) solution of triphenyl tetrazolium in phosphate buffer was infused into a side arm of the aortic cannula until the myocardium stained deep red. 17 The hearts were excised, weighed, and stored at Ϫ70°C for subsequent determination of infarct size as described previously. 16, 17 
Determination of Reactive Oxygen Species in the Heart
To estimate oxygen free radicals, an additional group of wild-type, Sod I ϩ/Ϫ , and Sod I Ϫ/Ϫ hearts were perfused for 15 minutes in the presence of 2 mmol/L salicylate before ischemia as described previously. 18 At the end of the 2 hours of reperfusion, hearts were frozen at Ϫ70°C for subsequent analysis of hydroxylated benzoic acids by HPLC using an electrochemical detector. 18 Additionally, malonaldehyde was assayed 19 to monitor the development of oxidative stress during ischemia/reperfusion.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
Generation and Characterization of Sod I Knockout Mice
As shown in Figure 1 , exon 5 of the mouse Sod1 gene (which encodes the C terminus of the protein from amino acid residues 120 to 154, which constitute both the structure and function of the active site channel 20 ) and some of the flanking intron sequences were replaced with the neomycin resistance cassette (neo). This also creates a new PstI restriction site, resulting in a shorter PstI genomic fragment from the targeted allele (12.5 kb) than that from the wild-type allele (16.5 kb). Mice heterozygous (Sod I ϩ/Ϫ ) for the targeted allele were interbred to generate homozygous knockout (Sod1 Ϫ/Ϫ ) mice.
Male and female Sod1
Ϫ/Ϫ mice grew normally and were apparently healthy under routine animal husbandry.
Inactivation of the functional mouse Sod1 gene in mouse hearts by gene targeting was initially determined by RNA blot analysis. An Ϸ50% reduction of Cu/Zn-SOD mRNA was found in the heart of Sod1 ϩ/Ϫ mice compared with that of wild-type (Sod I ϩ/ϩ ) mice ( Figure 2A ). Furthermore, no Cu/Zn-SOD mRNA could be detected in Sod1 Ϫ/Ϫ heart, indicating that the truncated Cu/Zn-SOD or Cu/Zn-SOD-neo fusion mRNA is degraded rapidly in the heart. Reduction of heart Cu/Zn-SOD enzyme activity in Sod1 ϩ/Ϫ and Sod1 Ϫ/Ϫ mice was also confirmed by SOD activity staining on a native polyacrylamide gel. 21 Figure 2B shows that the Cu/Zn-SOD activities in the hearts of Sod1
, Sod1 ϩ/Ϫ , and Sod1 Ϫ/Ϫ mice are proportional to the mRNA levels in these mice, as shown in Figure 2A . A decrease in Cu/Zn-SOD activity apparently had no effects on the activity of other heart antioxidant enzymes, such as manganese SOD (Mn-SOD) ( Figure 2B ), catalase; glutathione peroxidase; and enzymes involved in the recycling of oxidized glutathione, including glutathione reductase and glucose-6-phosphate dehydrogenase (data not shown). A more detailed characterization of the Cu/Zn-SODdeficient mice has been reported elsewhere. 22 Male and female Sod1 ϩ/ϩ and Sod1 Ϫ/Ϫ mice at 10 to 12 weeks of age were used for myocardial ischemia/reperfusion study.
Myocardial Performance
All hearts recovered their beats spontaneously after 30 minutes of global ischemia followed by reperfusion. However, the heart rates remained lowered compared with baseline (Figure 3, top) . No significant difference was found in heart rate between groups throughout the experiment. Coronary flow was significantly reduced after 30 minutes of reperfusion compared with baseline for all groups of mouse hearts (Figure 3, bottom) . Although coronary flow was progressively reduced up to 2 hours of reperfusion, there was no difference between the 3 groups of hearts. The baseline values of dF (0.63Ϯ0.07 g for wild type, 0.61Ϯ0.05 g for Sod I ϩ/Ϫ , and 0.57Ϯ0.08 g for Sod I Ϫ/Ϫ mice) and maximal first derivative of dF (dF/dt; 265Ϯ33 g/s for wild-type, 251Ϯ25 g/s for Sod I ϩ/Ϫ , and 233Ϯ27 g/s for Sod I Ϫ/Ϫ mice) did not vary significantly among the groups. The dF during reperfusion was lower for the Sod I Ϫ/Ϫ knockout mouse hearts than for control wild-type hearts throughout the reperfusion (Figure 4, top) . In wild-type and Sod I ϩ/Ϫ hearts, dF recovered to the level of baseline after 30 minutes of reperfusion, and this level was maintained higher than the baseline through the end of the experiment. On the other hand, dF did not recover beyond the 90% level of baseline for the Sod I Ϫ/Ϫ hearts. At all points, dF showed significantly lower recovery for Sod I Ϫ/Ϫ hearts compared with nontransgenic control and Sod I ϩ/Ϫ hearts after 15 minutes of reperfusion (PϽ0.05). A similar trend was seen in dF/dt max (Figure 4, bottom) . A significantly lower recovery of dF/dt max occurred in Sod I Ϫ/Ϫ hearts after 15 
minutes of reperfusion (PϽ0.05). These results demonstrate that Sod I
Ϫ/Ϫ mouse hearts showed significantly lower myocardial contractile recovery after 30 minutes of ischemia.
CK Release From Heart
Total CK release from the heart ( Figure 5 ), which reflects cellular injury or tissue necrosis and membrane permeability, was only Ϸ5 U/mL for all of the groups before ischemia. After ischemia, CK release was increased in all 3 groups, but the amount of release was much higher for the Sod I Ϫ/Ϫ knockout mouse hearts. For example, at 30 minutes of reperfusion, CK release was 122Ϯ8.7 IU/mL for Sod I Ϫ/Ϫ mice as compared with 70Ϯ6.8v IU/mL (PϽ0.05) for nontransgenic wild-type controls. The amount of CK release was progressively increased as the duration of reperfusion increased. At 60 minutes of reperfusion, CK release was 151Ϯ7.7 IU/mL for Sod I Ϫ/Ϫ mouse heart compared with 98Ϯ6.4 IU/mL (PϽ0.05) for nontransgenic controls. Similarly, after 120 minutes of reperfusion, CK release from the Sod I Ϫ/Ϫ mouse hearts amounted to 163Ϯ8.1 IU/mL compared with that from nontransgenic controls, which was 118Ϯ7.4 IU/mL. Amount of CK release from the hearts of Sod I ϩ/Ϫ mice was not significantly different from that from the wild-type mouse hearts at any point.
Myocardial Infarction
In this study, global ischemia for 30 minutes was adopted; therefore, the whole ventricle was regarded as the area of risk. The area that was not stained by triphenyl tetrazolium was measured and calculated as the infarct area. Infarct size for each heart was defined as percentage of area at risk. Mean value of infarct size in the Sod I Ϫ/Ϫ mouse heart group was significantly higher than that in the control group (38.8Ϯ3.3% versus 22.5Ϯ1.8% for the wild-type, PϽ0.05) ( Figure 6 ). Infarct size of the hearts from Sod I ϩ/Ϫ mouse hearts was similar to that of wild-type control. Our results indicated that Sod I Ϫ/Ϫ mouse heart mouse hearts had significantly higher myocardial necrosis.
Increased OH ⅐ Formation in the Sod I ؊/؊
Mouse Hearts
The levels of 2,3-dihydroxy benzoic acid (2,3-DHBA) in the hearts of wild-type, Sod I ϩ/Ϫ , and Sod I Ϫ/Ϫ mice are shown in Figure 7 . The OH ⅐ radical produces both 2,3-DHBA and 2,5-DHBA, but 2,5-DHBA may also be produced by the cytochrome P450 system. 17 We therefore monitored 2,3-DHBA formation, which truly reflects the production of OH ⅐ radical. Similar amounts of 2,3-DHBA were found in all 3 groups of hearts at baseline (before ischemia and reperfusion). The amount of 2,3-DHBA increased at the end of ischemia/reperfusion (after 2 hours of reperfusion) in all hearts, indicating an increased OH ⅐ formation. A significantly higher amount of 2,3-DHBA was noticed in the hearts of Sod I Ϫ/Ϫ mouse compared with Sod I ϩ/Ϫ mouse hearts and wildtype mouse hearts, demonstrating that significantly higher amounts of reactive oxygen species were formed in the Sod I Ϫ/Ϫ mouse hearts on ischemia and reperfusion.
Malonaldehyde (MDA) Formation
MDA formation is considered a presumptive marker for oxidative stress. MDA was measured as MDA-DNPH derivative by HPLC. MDA formation was increased progressively and steadily during the postischemic reperfusion in all 3 group of hearts (Figure 8) . However, the amount of MDA production was significantly higher at all points in the Sod I Ϫ/Ϫ mouse hearts compared with those for wild-type and Sod I ϩ/Ϫ mouse hearts, demonstrating that Sod I Ϫ/Ϫ mouse hearts were subjected to an increased amount of oxidative stress during the postischemic reperfusion.
Discussion
The results of this study documented that Sod I Ϫ/Ϫ mouse hearts are more susceptible to ischemic reperfusion injury ϩ/Ϫ ( o ), and Sod1 Ϫ/Ϫ ( u ) mouse hearts. 2,3-DHBA was measured at baseline (before ischemia) and after ischemia/reperfusion (at the end of 2 hours of reperfusion) by HPLC using an electrochemical detector as described in Materials and Methods. Results are shown as meanϮSEM of 6 hearts in each group. *PϽ0.05 compared with control. SOD is present in both the cytosolic and the mitochondrial fractions of the mammalian heart. A significant number of studies exist in the literature to show the cardioprotective role of mitochondrial SOD or Mn-SOD. For example, overexpression of Mn-SOD has been found to protect myocardial ischemia/reperfusion injury in transgenic mice. 5 Increased expression of Mn-SOD in the hearts transfected with Mn-SOD showed significant improvement in tolerance against ischemia/reperfusion injury. 23 The activation of Mn-SOD by the free radicals produced during hyperthermia was found to be important for early-phase and late-phase cardioprotection against ischemia/reperfusion injury in rats. In another related study, the same investigators have found that heat shockinduced Mn-SOD enhanced the tolerance of cardiac myocytes to hypoxia-reoxygenation injury. 24 Preconditioning of a heart by cyclic episodes of ischemia and reperfusion has been found to induce Mn-SOD, suggesting its importance in the myocardial defense mechanism. 25 Mn-SOD could protect mitochondrial complex I against Adriamycin-induced cardiomyopathy in transgenic mice. 26 Another recent study also showed the induction of Mn-SOD, 27 supporting this previous observation.
In contrast, only a little information is available regarding the cardioprotective ability of cytosolic Cu/Zn-SOD. Initial studies have resulted in conflicting reports, showing Cu/Zn-SOD to be both protective and nonprotective. 28 Efficacy of Cu/Zn-SOD in cardioprotection was believed to be limited by its inability to enter the cells, 29 as well as by its nonspecific deleterious effects. 30 However, our initial study has shown Cu/Zn-SOD to be cardioprotective against ischemia/reperfusion injury. 31 A recent study has indicated that overexpression of human Cu/Zn-SOD prevents postischemic injury. 9 The present study supports this previous report and further documents that Sod I Ϫ/Ϫ mouse hearts are subjected to an increased amount of oxidative stress during ischemia and reperfusion. The amount of 2,3-DHBA was the highest in the hearts of Sod I Ϫ/Ϫ mouse, indicating a significantly higher amount of OH ⅐ radical formation in these hearts compared with either wildtype or Sod I ϩ/Ϫ mouse hearts. Sod I ϩ/Ϫ mouse hearts contained Ϸ50% of the mRNA and enzyme activity compared with wild-type mouse hearts. Our results indicate that 50% of the total Sod I activity provided a comparable degree of cardioprotection (as compared with wild-type hearts) against ischemia/reperfusion injury.
A large number of studies exist in literature demonstrating development of oxidative stress due to increased formation of reactive oxygen species and decreased antioxidant reserve in the ischemic reperfused myocardium. 32, 33 The reactive oxygen species include superoxide anions and hydroxyl and peroxyl radicals, as well as oxidants such as H 2 O 2 . 32 Mammalian hearts are protected from the oxidant challenge by several defense systems, which include antioxidant enzymes such as SOD, catalase, and glutathione peroxidase, and antioxidants, which include glutathione, ascorbic acid, and ␣-tocopherol. 33 Our results imply that Cu/Zn-SOD may also be a part of the antioxidant reserve, because Sod I Ϫ/Ϫ mouse hearts were subjected to increased oxidative stress in concert with increased ischemic/reperfusion injury. 
